Advertisement
Australia markets closed

  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     

  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     

  • AUD/USD

    0.6501
    +0.0001 (+0.02%)
     

  • OIL

    82.78
    -0.03 (-0.04%)
     

  • GOLD

    2,321.90
    -16.50 (-0.71%)
     

  • Bitcoin AUD

    98,933.51
    -3,525.45 (-3.44%)
     

  • CMC Crypto 200

    1,386.84
    -37.26 (-2.61%)
     

  • AUD/EUR

    0.6070
    -0.0000 (-0.00%)
     

  • AUD/NZD

    1.0948
    +0.0006 (+0.05%)
     

  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     

  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     

  • DAX

    18,088.70
    -48.95 (-0.27%)
     

  • Hang Seng

    17,346.72
    +145.45 (+0.85%)
     

  • NIKKEI 225

    37,818.11
    -641.97 (-1.67%)
     

Optinose to Present at the Cantor Virtual Global Healthcare Conference

OptiNose, Inc.
·1-min read

YARDLEY, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the Cantor Virtual Global Healthcare Conference on September 28, 2021, at 8:40 a.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.

Optinose Investor Contact

Jonathan Neely
jonathan.neely@optinose.com
267.521.0531